176 related articles for article (PubMed ID: 19680529)
1. Best of the 2009 AUA Annual Meeting: Highlights from the 2009 Annual Meeting of the American Urological Association, April 25-30, 2009, Chicago, IL.
Brawer MK; Loeb S; Partin AW; Yoshimura N; Chancellor MB; Roehrborn CG; Assimos DG; Nickel JC; Shuch B; Pouliot F; Belldegrun AS; Shapiro E
Rev Urol; 2009; 11(2):82-107. PubMed ID: 19680529
[No Abstract] [Full Text] [Related]
2. Best of the 2007 AUA Annual Meeting: Highlights from the 2007 Annual Meeting of the American Urological Association, May 19-24, 2007, Anaheim, CA.
Brawer MK; Makarov DV; Partin AW; Roehrborn CG; Curtis Nickel J; Chancellor MB; Assimos DG; Shapiro E; Rajfer J
Rev Urol; 2007; 9(3):133-54. PubMed ID: 17934570
[No Abstract] [Full Text] [Related]
3. Best of the 2008 AUA Annual Meeting: Highlights from the 2008 Annual Meeting of the American Urological Association, May 17-22, 2008, Orlando, FL.
Brawer MK; Makarov DV; Partin AW; Roehrborn CG; Nickel JC; Lu SH; Yoshimura N; Chancellor MB; Assimos DG
Rev Urol; 2008; 10(2):136-56. PubMed ID: 18660856
[No Abstract] [Full Text] [Related]
4. Best of the AUA Annual Meeting: Highlights From the 2010 American Urological Association Meeting, May 29-June 3, 2010, San Francisco, CA.
Nickel JC; Furuta A; Chancellor MB; Roehrborn CG; Assimos DG; Shapiro E; Brawer MK
Rev Urol; 2010; 12(2-3):e134-46. PubMed ID: 20811551
[No Abstract] [Full Text] [Related]
5. The American Urological Association 2003 guideline on management of benign prostatic hyperplasia: a Canadian opinion.
Nickel JC; Saad F
Can J Urol; 2004 Apr; 11(2):2186-93. PubMed ID: 15182407
[TBL] [Abstract][Full Text] [Related]
6. Best of the 2017 AUA Annual Meeting: Highlights From the 2017 American Urological Association Annual Meeting, May 12-16, 2017, Boston, MA.
Arcila-Ruiz MJ; Assimos DG; Brucker BM; Chancellor MB; Druskin SC; Curtis Nickel J; Partin AW; Shapiro E
Rev Urol; 2017; 19(3):169-179. PubMed ID: 29302240
[No Abstract] [Full Text] [Related]
7. Fourth joint meeting of the American Urological Association and the Japanese Urological Association Specialty Society program at the 104th annual meeting of the American Urological Association at Chicago 2009.
Cooperberg MR; Hinotsu S; Chancellor MB; Homma Y; Nelson PS; Matsuyama H; Menon M; Kucuk O; Hara I; Egawa S; Uzzo RG; Kanayama HO; Okuyama A; Akaza H
Int J Urol; 2009 Aug; 16(8):703-8. PubMed ID: 19682110
[TBL] [Abstract][Full Text] [Related]
8. Silodosin 8 mg improves benign prostatic obstruction in Caucasian patients with lower urinary tract symptoms suggestive of benign prostatic enlargement: results from an explorative clinical study.
Fusco F; Creta M; Longo N; Persico F; Franco M; Mirone V
BMC Urol; 2018 Mar; 18(1):12. PubMed ID: 29502524
[TBL] [Abstract][Full Text] [Related]
9. Best of the 2019 AUA Annual Meeting: Highlights From the 2019 American Urological Association Annual Meeting, May 3-6, 2019, Chicago, IL.
Rev Urol; 2019; 21(2-3):109-117. PubMed ID: 31768138
[No Abstract] [Full Text] [Related]
10. Best of the 2014 AUA Annual Meeting: Highlights From the 2014 American Urological Association Annual Meeting, May 16-21, 2014, Orlando, FL.
Kern AJ; Partin AW; Shapiro E
Rev Urol; 2014; 16(3):139-44. PubMed ID: 25337046
[No Abstract] [Full Text] [Related]
11. Impact of phytotherapy on utility scores for 5 benign prostatic hyperplasia/lower urinary tract symptoms health states.
Dedhia RC; Calhoun E; McVary KT
J Urol; 2008 Jan; 179(1):220-5. PubMed ID: 18001791
[TBL] [Abstract][Full Text] [Related]
12. Best of the 2016 AUA Annual Meeting: Highlights From the 2016 American Urological Association Annual Meeting, May 6-10, 2016, San Diego, CA.
Nickel JC; Gorin MA; Alan W P; Loeb S; Ellen S; Chancellor MB; Assimos DG; Brawer MK; Brucker BM
Rev Urol; 2016; 18(3):159-173. PubMed ID: 27833468
[No Abstract] [Full Text] [Related]
13. Best of the 2003 AUA Annual Meeting: Highlights from the 2003 Annual Meeting of the American Urological Association, April 26-May 1, 2003, Chicago, IL.
Rev Urol; 2003; 5(3):156-81. PubMed ID: 16985637
[No Abstract] [Full Text] [Related]
14. The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study.
Roehrborn CG; Gange SN; Shore ND; Giddens JL; Bolton DM; Cowan BE; Brown BT; McVary KT; Te AE; Gholami SS; Rashid P; Moseley WG; Chin PT; Dowling WT; Freedman SJ; Incze PF; Coffield KS; Borges FD; Rukstalis DB
J Urol; 2013 Dec; 190(6):2161-7. PubMed ID: 23764081
[TBL] [Abstract][Full Text] [Related]
15. Best of the AUA Annual Meeting: Highlights From the 2011 American Urological Association Meeting, May 14-19, 2011, Washington, DC.
Brawer MK; Loeb S; Partin AW; Nirmal J; Chancellor MB; Nickel JC; Rajfer J; Shapiro E; Roehrborn CG
Rev Urol; 2011; 13(3):151-72. PubMed ID: 22114546
[No Abstract] [Full Text] [Related]
16. Best of the 2013 AUA Annual Meeting: Highlights From the 2013 American Urological Association Meeting, May 4-8, 2013, San Diego, CA.
Loeb S; Assimos D; Chancellor MB; Nickel JC; Brawer MK; Kern AJ; Partin AW
Rev Urol; 2013; 15(2):72-81. PubMed ID: 24082846
[No Abstract] [Full Text] [Related]
17. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate.
Wasson JH; Reda DJ; Bruskewitz RC; Elinson J; Keller AM; Henderson WG
N Engl J Med; 1995 Jan; 332(2):75-9. PubMed ID: 7527493
[TBL] [Abstract][Full Text] [Related]
18. Silodosin versus naftopidil in Japanese patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized multicenter study.
Shirakawa T; Haraguchi T; Shigemura K; Morishita S; Minayoshi K; Miyazaki J; Yamada Y; Miyake H; Tanaka K; Fujisawa M
Int J Urol; 2013 Sep; 20(9):903-10. PubMed ID: 23252453
[TBL] [Abstract][Full Text] [Related]
19. Similarity of the American Urological Association Symptom Index among men with benign prostate hyperplasia (BPH), urethral obstruction not due to BPH and detrusor hyperreflexia without outlet obstruction.
Chancellor MB; Rivas DA; Keeley FX; Lotfi MA; Gomella LG
Br J Urol; 1994 Aug; 74(2):200-3. PubMed ID: 7522872
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and safety of silodosin in the treatment of lower urinary tract symptoms in patients with benign prostatic hyperplasia: A European phase IV clinical study (SiRE study).
Montorsi F; Gandaglia G; Chapple C; Cruz F; Desgrandchamps F; Llorente C
Int J Urol; 2016 Jul; 23(7):572-9. PubMed ID: 26969887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
